ESMO Sarcoma and Rare Cancers 2023 | Current challenges associated with immunotherapy in treating STS

Zuzana Strizova, MD, PhD, Charles University, Prague, Czech Republic, discusses the limitations that can hinder the efficacy of adoptive cell transfer and CAR T-cell therapy in the treatment of soft tissue sarcoma. The lack of tumor associated antigens coupled with the vast heterogeneity of these tumor types serve as hindrances when it comes to the development of targeted therapies and study design. This interview took place at the ESMO Sarcoma and Rare Cancers Congress 2023 in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.